Invention Application
- Patent Title: GUANIDINE DERIVATIVES FOR THE TREATMENT OF HEPATITIS C
- Patent Title (中): 用于治疗乙型肝炎的胍基衍生物C
-
Application No.: US14762542Application Date: 2014-01-23
-
Publication No.: US20150320757A1Publication Date: 2015-11-12
- Inventor: TAO WANG , Zhongxing Zhang , Ying Han , Zhiwei Yin , Paul Michael Scola
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- International Application: PCT/US14/12639 WO 20140123
- Main IPC: A61K31/53
- IPC: A61K31/53 ; C07D403/12 ; A61K31/551 ; C07D251/52 ; A61K45/06
Abstract:
Compounds of Formula I, including pharmaceutically acceptable salts thereof, are set forth, in addition to compositions and methods of using these compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
Public/Granted literature
- US09655902B2 Guanidine derivatives for the treatment of hepatitis C Public/Granted day:2017-05-23
Information query
